Target intelligence / Profile preview

Peptidyl-prolyl cis-trans isomerase-like 1 (PPIL1)

Target
PPIL1
Molecular classification
Enzyme, Isomerase, Cyclophilin family, Protein folding chaperone, Spliceosome complex component
01

Overview

Peptidyl-prolyl cis-trans isomerase-like 1 (PPIL1) is an enzyme encoded by the PPIL1 gene in humans, belonging to the cyclophilin family of peptidylprolyl isomerases. It catalyzes the cis-trans isomerization of proline residues in peptides, facilitating protein folding and acting as a molecular chaperone. PPIL1 is a component of the spliceosome, the complex responsible for pre-mRNA splicing in eukaryotic cells, and interacts with factors such as SKIP to promote structural rearrangement and activation of the spliceosome during RNA processing. In addition to its enzymatic role, PPIL1 is functionally involved in embryonic brain development, independently of its isomerase activity, and genetic defects in PPIL1 are associated with pontocerebellar hypoplasia. The protein is widely conserved and structurally resembles other cyclophilins, and while it may share interactions typical to its family (such as binding cyclosporin A), it does not currently have specific drugs or established biomarker applications in clinical practice. If further information or structured data is needed, consult authoritative genetic and proteomic databases using the UniProt Q9Y3C6 or NCBI Gene ID 51645 for PPIL1.

Other names
CYPL1PPIasehCyPXCGI-124PCH14rotamase PPIL1cyclophilin-like 1cyclophilin-related gene 1peptidyl-prolyl isomerase (cyclophilin)-like 1UNQ2425/PRO4984
02

Mechanism of action

Inhibition of peptidyl-prolyl isomerase activity (for cyclophilins, e.g., by cyclosporin A)

03

Biological functions

Pre-mRNA splicing (spliceosome activation and function)Protein folding via cis-trans isomerization of proline bondsPotential molecular chaperone activity within spliceosomal processesEmbryonic brain development (independent of isomerase activity)
04

Disease associations

Pontocerebellar hypoplasia (Type 14 and related forms)Potential involvement in neurodevelopmental disordersOther roles speculative or under exploration; no strong evidence for cancer, infection, etc. at present
05

Safety considerations

No notable safety concerns or therapeutic liabilities explicitly documented for PPIL1 as a drug target as of current literature. General concerns for cyclophilin family members include immunosuppression by cyclosporin A, but this is not uniquely attributable to PPIL1
06

Interacting drugs

Cyclosporin A
07

Biomarkers

None explicitly described for PPIL1. Its gene or protein expression could theoretically be monitored in research studies of brain development or pontocerebellar hypoplasia

Beyond the preview

Go deeper on Peptidyl-prolyl cis-trans isomerase-like 1 (PPIL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidyl-prolyl cis-trans isomerase-like 1 (PPIL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call